A detailed history of Bullseye Asset Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Bullseye Asset Management LLC holds 184,820 shares of CDNA stock, worth $5.72 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
184,820
Previous 174,820 5.72%
Holding current value
$5.72 Million
Previous $1.85 Million 55.02%
% of portfolio
1.41%
Previous 0.87%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$7.56 - $16.15 $75,600 - $161,500
10,000 Added 5.72%
184,820 $2.87 Million
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $24,500 - $64,300
5,000 Added 2.94%
174,820 $2.1 Million
Q3 2023

Nov 15, 2023

BUY
$7.0 - $11.26 $140,000 - $225,200
20,000 Added 13.35%
169,820 $1.19 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $878,355 - $1.75 Million
99,474 Added 197.58%
149,820 $1.37 Million
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $217,600 - $401,000
20,000 Added 65.91%
50,346 $574,000
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $5,460 - $8,972
-340 Reduced 1.11%
30,346 $517,000
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $471 - $913
23 Added 0.08%
30,686 $659,000
Q4 2021

Feb 15, 2022

BUY
$41.2 - $73.6 $412,000 - $736,000
10,000 Added 48.4%
30,663 $1.38 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $4,258 - $6,623
-72 Reduced 0.35%
20,663 $1.31 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $6,753 - $12,565
-163 Reduced 0.78%
20,735 $1.5 Million
Q3 2020

Nov 12, 2020

SELL
$30.88 - $37.94 $401 - $493
-13 Reduced 0.06%
20,898 $793,000
Q2 2020

Aug 11, 2020

BUY
$18.95 - $35.43 $396,263 - $740,876
20,911 New
20,911 $741,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.65B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.